Apyx Medical Corporation (APYX) |
| 2.9 0.01 (0.35%) 09-11 16:00 |
| Open: | 2.99 |
| High: | 3 |
| Low: | 2.79 |
| Volume: | 161,327 |
| Market Cap: | 122(M) |
| PE Ratio: | -14.5 |
| Exchange: | NASDAQ |
| Industry: | Medical - Specialties |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 4.25 |
| Resistance 1: | 3.69 |
| Pivot price: | 3.04 |
| Support 1: | 2.79 |
| Support 2: | 2.32 |
| 52w High: | 5.08 |
| 52w Low: | 1.7 |
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
| EPS | -0.200 |
| Book Value | 0.250 |
| PEG Ratio | 0.59 |
| Gross Profit | 0.881 |
| Profit Margin (%) | -14.78 |
| Operating Margin (%) | -13.01 |
| Return on Assets (ttm) | -3.7 |
| Return on Equity (ttm) | -90.7 |
Thu, 06 Aug 2026
Apyx Medical Corporation (APYX) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Thu, 06 Aug 2026
Apyx Medical Corporation Reports Second Quarter 2026 Financial Results - Yahoo Finance
Tue, 28 Jul 2026
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference - GlobeNewswire
Thu, 23 Jul 2026
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - GlobeNewswire
Fri, 19 Jun 2026
Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity - Yahoo Finance
Mon, 01 Jun 2026
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |